{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:06:59Z","timestamp":1787242019446,"version":"build-2736575974"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["5U01AG006781\u201029"],"award-info":[{"award-number":["5U01AG006781\u201029"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The purpose of the study is to determine if the use of a proton pump inhibitor (PPI) is associated with an increased fracture risk, as some prior studies have suggested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included data on 4438 participants aged 65 and older who had no fracture in the year prior to baseline and had \u22655\u00a0years of enrollment history in Kaiser Permanente Washington, an integrated healthcare delivery system in Seattle, WA, during 1994 to 2014. Time\u2010varying cumulative exposure to PPIs was determined from automated pharmacy data by summing standard daily doses (SDDs) across fills, and patients were categorized as no use (reference group, \u226430 SDD), light use (31\u2010540 SDD), moderate use (541\u20101080 SDD), and heavy use (\u22651081 SDD). Incident fractures were assessed using International Classification of Diseases, Ninth Revision codes from electronic medical records. Potential confounders, chosen a priori, were assessed at baseline and at each 2\u2010year follow\u2010up visit. Fracture risk was analyzed using a Cox proportional hazards model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a mean follow\u2010up of 6.1\u00a0years, 802 (18.1%) participants experienced a fracture. No overall association was found between PPI use and fracture risk. Adjusted hazard ratios comparing users to the referent category were 1.08 (95% CI 0.83\u20101.40) for light users, 1.31 (95% CI 0.86\u20101.95) for moderate users, and 0.95 (95% CI 0.68\u20101.34) for heavy users. Among patients with SSD\u00a0&gt;\u00a030, no appreciable increase in fracture risk was present in persons with recent versus distant use (adjusted hazard ratio of 1.14 [95% CI 0.91\u20101.42]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No association was observed between PPI use and fracture risk among older adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pds.4406","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T20:02:40Z","timestamp":1519848160000},"page":"596-603","source":"Crossref","is-referenced-by-count":20,"title":["Proton pump inhibitor use and the risk of fractures among an older adult cohort"],"prefix":"10.1002","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9460-9399","authenticated-orcid":false,"given":"Barbara N.","family":"Harding","sequence":"first","affiliation":[{"name":"Department of Epidemiology University of Washington  Seattle WA USA"},{"name":"Kaiser Permanente Washington Health Research Institute  Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel S.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Epidemiology University of Washington  Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod L.","family":"Walker","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute  Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Larson","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute  Seattle WA USA"},{"name":"Division of General Internal Medicine, Department of Medicine University of Washington  Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6649-3659","authenticated-orcid":false,"given":"Sascha","family":"Dublin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology University of Washington  Seattle WA USA"},{"name":"Kaiser Permanente Washington Health Research Institute  Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.04.014"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2279"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e372"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.333.7557.27"},{"key":"e_1_2_13_6_1","first-page":"1","article-title":"Hip fracture epidemiological trends, outcomes, and risk factors, 1970\u20102009","volume":"3","author":"Marks R","year":"2010","journal-title":"Int J Gen Med"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2006.04.004"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-008-9170-1"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.94"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2026"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071330"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2112-9"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.8.951"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.03.055"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-006-0021-7"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2947"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.11.1737"},{"key":"e_1_2_13_18_1","first-page":"234","volume-title":"Pharmacoepidemiology","author":"Saunders KWDR","year":"2005"},{"key":"e_1_2_13_19_1","unstructured":"WHO. ATC\/DDD system. Volume 2016 2009."},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-11-326"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.07.008"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-003-0613-0"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.20.2381"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2394-6"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(18)30622-6"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610294001602"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-015-0022-3"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2014.05.019"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-008-9188-4"},{"issue":"8","key":"e_1_2_13_31_1","first-page":"084905","article-title":"Self\u2010reported medication use validated through record linkage to national prescribing data","volume":"147","author":"Hafferty JD","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.12.012"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.4406","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.4406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T12:17:48Z","timestamp":1695471468000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.4406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1002\/pds.4406"],"URL":"https:\/\/doi.org\/10.1002\/pds.4406","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]}}}